{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:41:22Z","timestamp":1794336082623,"version":"4.9.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ctrv.2020.102012","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T17:41:45Z","timestamp":1584639705000},"page":"102012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Parathyroid cancer: An update"],"prefix":"10.1016","volume":"86","author":[{"given":"Juan P.","family":"Rodrigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Hernandez-Prera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Zafereo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol R.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti A.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok R.","family":"Shaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Ferlito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2020.102012_b0005","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","article-title":"Clinical presentation, staging and long term evolution of parathyroid cancer","volume":"17","author":"Talat","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","article-title":"Update on parathyroid carcinoma","volume":"39","author":"Cetani","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ctrv.2020.102012_b0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.beem.2018.11.002","article-title":"Parathyroid carcinoma","volume":"32","author":"Salcuni","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2020.102012_b0020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A nationwide study on parathyroid carcinoma","volume":"56","author":"Ryh\u00e4nen","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0025","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.surg.2014.08.069","article-title":"Parathyroid carcinoma in more than 1,000 patients: A population-level analysis","volume":"156","author":"Sadler","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ctrv.2020.102012_b0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.surg.2014.05.014","article-title":"Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study","volume":"156","author":"Villar-del-Moral","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ctrv.2020.102012_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cen.13055","article-title":"Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients","volume":"85","author":"Xue","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ctrv.2020.102012_b0040","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2020.102012_b0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hed.21376","article-title":"Parathyroid carcinoma: a review","volume":"33","author":"Owen","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2020.102012_b0050","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","article-title":"Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis","volume":"202","author":"Schaapveld","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctrv.2020.102012_b0055","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.surg.2014.08.005","article-title":"Is central lymph node dissection necessary for parathyroid carcinoma?","volume":"156","author":"Hsu","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ctrv.2020.102012_b0060","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jso.24407","article-title":"Oncologic progress for the treatment of parathyroid carcinoma is needed","volume":"114","author":"Christakis","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0070","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jamcollsurg.2017.01.060","article-title":"Prognostic scoring system to risk stratify parathyroid carcinoma","volume":"224","author":"Silva-Figueroa","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ctrv.2020.102012_b0075","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.ejca.2012.01.029","article-title":"Links TP; RARECARE WG. Carcinoma of endocrine organs: Results of the RARECARE project","volume":"48","author":"van der Zwan","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2020.102012_b0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1245\/s10434-015-4901-9","article-title":"The incidence and survival of rare cancers of the thyroid, parathyroid, adrenal, and pancreas","volume":"23","author":"James","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0085","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102012_b0090","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.beem.2018.11.001","article-title":"Molecular pathogenesis of parathyroid tumours","volume":"32","author":"Cinque","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2020.102012_b0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the genetic basis of parathyroid carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0100","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2020.102012_b0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ctrv.2020.102012_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","article-title":"Immunohistochemistry in Diagnostic Parathyroid Pathology","volume":"29","author":"Erickson","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0115","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ctrv.2020.102012_b0120","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.ctrv.2020.102012_b0125","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ctrv.2020.102012_b0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","article-title":"Parathyroid carcinoma. A study of 70 cases","volume":"31","author":"Schantz","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102012_b0140","series-title":"WHO Classification of Tumours of Endocrine Organs","first-page":"147","article-title":"Parathyroid carcinoma","author":"De Lellis","year":"2017"},{"key":"10.1016\/j.ctrv.2020.102012_b0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.path.2014.08.004","article-title":"Parathyroid: the pathology of hyperparathyroidism","volume":"7","author":"LiVolsi","year":"2014","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.ctrv.2020.102012_b0150","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","article-title":"Histopathological variables and DNA cytometry in parathyroid carcinoma","volume":"17","author":"Bondeson","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.ctrv.2020.102012_b0155","first-page":"80","article-title":"Parathyroid carcinoma: diagnosis and clinical implications","volume":"31","author":"Duan","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.ctrv.2020.102012_b0160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fendo.2019.00731","article-title":"The Clinicopathological Spectrum of Parathyroid Carcinoma","volume":"10","author":"Akirov","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ctrv.2020.102012_b0165","series-title":"Pancreatic Neuroendocrine Neoplasms","first-page":"125","article-title":"Pancreatic neuroendocrine tumors producing GHRH, GH, ghrelin, PTH, or PTHrP","author":"Duan","year":"2015"},{"key":"10.1016\/j.ctrv.2020.102012_b0170","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAI.0000000000000007","article-title":"Value of GATA3 immunostaining in the diagnosis of parathyroid tumors","volume":"22","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ctrv.2020.102012_b0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0046-8177(95)90028-4","article-title":"Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining","volume":"26","author":"Abbona","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s002689900567","article-title":"Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease","volume":"23","author":"Farnebo","year":"1999","journal-title":"World J Surg"},{"key":"10.1016\/j.ctrv.2020.102012_b0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02738728","article-title":"Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas","volume":"6","author":"Lloyd","year":"1995","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0200","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0205","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<378::AID-CNCR3>3.0.CO;2-F","article-title":"Parathyroid carcinoma: a diagnostic and therapeutic challenge","volume":"86","author":"Shaha","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102012_b0210","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrendo.2012.102","article-title":"Diagnosis and management of parathyroid cancer","volume":"8","author":"Schulte","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ctrv.2020.102012_b0215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00774-011-0344-y","article-title":"Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism","volume":"3","author":"Campenni","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ctrv.2020.102012_b0220","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3346\/jkms.2012.27.8.890","article-title":"Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"27","author":"Bae","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ctrv.2020.102012_b0225","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.21037\/qims.2019.07.02","article-title":"Semi-quantitative analysis of 99mTc-sestamibi retention level for preoperative differential diagnosis of parathyroid carcinoma","volume":"9","author":"Zhang","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.ctrv.2020.102012_b0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0194599813491063","article-title":"Ultrasound for localization in primary hyperparathyroidism","volume":"149","author":"Smith","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctrv.2020.102012_b0235","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00330-011-2141-3","article-title":"Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm","volume":"21","author":"Sidhu","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctrv.2020.102012_b0240","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0284185116666418","article-title":"Differentiation of parathyroid carcinoma and adenoma by preoperative ultrasonography","volume":"58","author":"Nam","year":"2017","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ctrv.2020.102012_b0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.48.213","article-title":"Ultrasonographic features of parathyroid carcinoma","volume":"48","author":"Hara","year":"2001","journal-title":"Endocr J"},{"key":"10.1016\/j.ctrv.2020.102012_b0250","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11604-019-00825-3","article-title":"CT features of parathyroid carcinomas: comparison with benign parathyroid lesions","volume":"37","author":"Takumi","year":"2019","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.ctrv.2020.102012_b0255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11547-018-0970-8","article-title":"MRI findings and utility of DWI in the evaluation of solid parathyroid lesions","volume":"124","author":"Yildiz","year":"2019","journal-title":"Radiol Med"},{"key":"10.1016\/j.ctrv.2020.102012_b0260","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/hed.25781","article-title":"American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism","volume":"41","author":"Zafereo","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ctrv.2020.102012_b0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5306\/wjco.v2.i10.348","article-title":"FDG-PET\/CT and parathyroid carcinoma: review of literature and illustrative case series","volume":"2","author":"Evangelista","year":"2011","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0270","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1007\/s00330-017-5190-4","article-title":"Benefit of 18 F-fluorocholine PET imaging in parathyroid surgery","volume":"28","author":"Huber","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctrv.2020.102012_b0275","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00259-015-3130-6","article-title":"18Fluorocholine PET\/CT in parathyroid carcinoma: a new tool for disease staging?","volume":"42","author":"Deandreis","year":"2015","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ctrv.2020.102012_b0280","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.oraloncology.2018.09.009","article-title":"18F-Choline-PET in parathyroid carcinoma","volume":"86","author":"Morand","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0285","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/RLU.0000000000002814","article-title":"18F-fluorocholine PET\/CT imaging of brown tumors in a patient with severe primary hyperparathyroidism","volume":"44","author":"Zhang-Yin","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ctrv.2020.102012_b0290","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00423-006-0095-8","article-title":"Implantation of parathyroid carcinoma along fine needle aspiration track","volume":"391","author":"Agarwal","year":"2006","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ctrv.2020.102012_b0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12105-017-0850-x","article-title":"Metastases to the parathyroid glands: a comprehensive literature review of 127 reported cases","volume":"12","author":"Bauer","year":"2018","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ctrv.2020.102012_b0300","first-page":"377","article-title":"Hypercalcemia and cancer: Differential diagnosis and treatment","volume":"68","author":"Zagzag","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2020.102012_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/sonc.2002.37417","article-title":"Treatment of hypercalcemia of malignancy with bisphosphonates","volume":"29","author":"Berenson","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0310","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-14-0166","article-title":"Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab","volume":"171","author":"Karuppiah","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ctrv.2020.102012_b0315","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2020.102012_b0320","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2020.102012_b0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management","volume":"1","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0330","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1245\/s10434-014-3530-z","article-title":"Oncologic resection achieving R0 margins improves disease-free survival in parathyroid cancer","volume":"21","author":"Schulte","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0335","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1245\/s10434-015-4673-2","article-title":"Parathyroid carcinoma: is it time for change?","volume":"22","author":"Schneider","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.prro.2017.05.009","article-title":"Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years","volume":"7","author":"Christakis","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0345","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1984.00350140229032","article-title":"Esselstyn C. Successful combination chemotherapy for metastatic parathyroid carcinoma","volume":"144","author":"Bukowski","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ctrv.2020.102012_b0350","first-page":"16","article-title":"Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases","volume":"2017","author":"Rozhinskaya","year":"2017","journal-title":"Endocrinol Diab Metab Case Rep"},{"key":"10.1016\/j.ctrv.2020.102012_b0355","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102012_b0360","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4066\/AMJ.2014.2084","article-title":"Metastatic parathyroid carcinoma treated with radiofrequency ablation: a novel therapeutic modality","volume":"7","author":"DasGuPA","year":"2014","journal-title":"Australas Med J"},{"key":"10.1016\/j.ctrv.2020.102012_b0365","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2265.2008.03238.x","article-title":"Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism","volume":"69","author":"Stratigis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ctrv.2020.102012_b0370","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Conn"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220300505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220300505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:22:50Z","timestamp":1759656170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737220300505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":74,"alternative-id":["S0305737220300505"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.102012","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid cancer: An update","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.102012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102012"}}